UBS Asset Management Americas sharply increased its Regeneron stake by 30.1%, snapping up 226,952 additional shares in Q4.

Regeneron Pharmaceuticals saw a major boost in hedge fund interest last quarter, with Scientech Research LLC increasing its ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its ...

The S&P 500 slipped 0.4% on Tuesday, May 20, snapping a six-day winning streak as investors' confidence on trade and ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

To acquire Personal Genome Service, Total Health and Research Services business lines, and its Biobank and associated assets.

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...